| Identification | Back Directory | [Name]
10,13,16-Trioxa-6,20-diazapentacosanoic acid, 25-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-5,21-dioxo- | [CAS]
1202761-21-4 | [Synonyms]
10,?13,?16-?Trioxa-?6,?20-?diazapentacosanoic acid, 25-?[(3aS,?4S,?6aR)?-?hexahydro-?2-?oxo-?1H-?thieno[3,?4-?d]?imidazol-?4-?yl]?-?5,?21-?dioxo- | [Molecular Formula]
C25H44N4O8S | [MOL File]
1202761-21-4.mol | [Molecular Weight]
560.7 |
| Chemical Properties | Back Directory | [Boiling point ]
893.4±65.0 °C(Predicted) | [density ]
1.189±0.06 g/cm3(Predicted) | [solubility ]
DMSO : 250 mg/mL (445.87 mM; Need ultrasonic) | [form ]
Solid | [pka]
4.65±0.10(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Biotinyl-NH-PEG3-C3-amido-C3-COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | [IC 50]
PEGs | [References]
[1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562. DOI:10.1016/j.ebiom.2018.09.005 |
|
|